Geoff Green
Directeur/Membre du Conseil chez BioFlorida, Inc.
Profil
Geoff Green is currently the Director at BioFlorida, Inc. He previously worked as a Director of Clinical Affairs at Innovative Drug Delivery Systems, Inc., Javelin Pharmaceuticals, Inc., and as a Vice President of Clinical Affairs at Accu-Break Pharmaceuticals, Inc. He was also the President, Chief Executive & Operating at Soligenix, Inc. and Vice President of Operations at Partikula LLC.
Additionally, he worked as a Principal at Memorial Sloan Kettering Cancer Center and as a Senior Vice President of Clinical Operations at Longeveron, Inc. He also served as the VP of Business Development & Operations at Heart Genomics LLC.
Mr. Green received his undergraduate degree from Kenyon College and his MBA from Andreas School of Business.
Postes actifs de Geoff Green
| Sociétés | Poste | Début |
|---|---|---|
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Geoff Green
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVERON INC. | Directeur Général | 01/06/2022 |
Innovative Drug Delivery Systems, Inc.
 Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments. | Corporate Officer/Principal | - |
Heart Genomics LLC
 Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Directeur des opérations | - |
| Partikula LLC | Directeur des opérations | - |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Geoff Green
| Kenyon College | Undergraduate Degree |
| Andreas School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| LONGEVERON INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Accu-Break Pharmaceuticals, Inc.
 Accu-Break Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accu-Break Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm develops tablets that are designed to improve and enhance the functionality of pharmaceutical tablets. The company was founded in 2001 by Lawrence Solomon and David Lucking headquartered in Plantation, FL. | Health Technology |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
| Paramount Capital, Inc. | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
| Partikula LLC | |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Commercial Services |
Innovative Drug Delivery Systems, Inc.
Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
